|
Report No. : |
260217.2 |
|
Report Date : |
21.02.2015 |
IDENTIFICATION DETAILS
|
Name : |
PHARMACHEMICALS HANDELS GMBH |
|
|
|
|
Registered Office : |
Spaldingstr. 210 D 20097 Hamburg |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
06.12.1996 |
|
|
|
|
Com. Reg. No.: |
HRB 62976 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
|
|
|
|
|
No. of Employee : |
5 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, has contributed to strong growth and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 5.3% in 2013. The new German government introduced a minimum wage of $11 per hour to take effect in 2015. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and in 2012 Germany reached a budget surplus of 0.1%. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016 though the target was already reached in 2012. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany hopes to replace nuclear power with renewable energy. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production.
|
Source
: CIA |
In the meantime there have been changes in
particular in the
following areas subject to monitoring:
-
Legal form
PHARMACHEMICALS
HANDELS GMBH
Company Status: active
Spaldingstr. 210
D 20097 Hamburg
Telephone:040/2369492
Telefax: 040/2369368
Homepage: www.pharmachemicals-gmbh.de
E-mail: info@pharmachemicals-gmbh.de
Business relations are permissible.
LEGAL FORM Private
limited company
Date of foundation: 1996
Shareholders'
agreement: 18.09.1996
Registered on: 06.12.1996
Commercial Register: Local court 20355 Hamburg
under: HRB
62976
EUR
50,000.00
Shareholder:
Dr. Avraam Sarafidis
Grenzknick 7
D 22043 Hamburg
born: 18.11.1961
Share: EUR 15,000.00
Shareholder:
Eleni Sarafidis
D 20097 Hamburg
born: 11.09.1985
Share: EUR 15,000.00
Shareholder:
Nikolaos Sarafidis
D 20097 Hamburg
born: 06.07.1989
Share: EUR 15,000.00
Shareholder:
Michaela Sarafidis
D 20097 Hamburg
born: 26.06.1958
Share: EUR 5,000.00
Manager:
Dr. Avraam Sarafidis
Grenzknick 7
D 22043 Hamburg
having sole power of
representation
born: 18.11.1961
Profession: Chemist
Proxy:
Michaela Sarafidis
D 20097 Hamburg
having sole power of
representation
born: 26.06.1958
Proxy:
Eleni Sarafidis
D 20097 Hamburg
having sole power of
representation
born: 11.09.1985
11.07.1997 - 31.12.1998 TRANSPHARMA and CHEMICALS Handels GmbH
Gotenstr. 13
D 20097 Hamburg
Private limited
company
Main industrial sector
46461
Wholesale of pharmaceutical goods
46760
Wholesale of other intermediate goods
Payment experience: within agreed terms
Negative information:We have no negative
information at hand.
Balance sheet year: 2012
Type of ownership: Tenant
Address Spaldingstr. 210
D 20097 Hamburg
Real Estate of: Dr. Avraam Sarafidis
Type of ownership: unknown
Address Grenzknick 7
D 22043 Hamburg
Land register documents were not available.
Principal bank
COMMERZBANK,
20454 HAMBURG
Sort. code: 20040000
BIC: COBADEHHXXX
Gross profit or loss:2012 EUR 2,972,035.00
Profit: 2012 EUR 1,103,842.00
Equipment: EUR 8,495.00
Ac/ts receivable: EUR 3,812,305.00
Liabilities: EUR 962,892.00
Employees:
5
-
Freelancer: 1
Balance sheet ratios 01.01.2012 - 31.12.2012
Equity ratio [%]: 79.58
Liquidity ratio: 10.00
Return on total capital [%]: 18.33
Balance
sheet ratios 01.01.2011 - 31.12.2011
Equity ratio [%]: 73.55
Liquidity ratio: 10.00
Return on total capital [%]: 21.39
Balance sheet ratios 01.01.2010 - 31.12.2010
Equity ratio [%]: 61.84
Liquidity ratio: 10.00
Return on total capital [%]: 20.04
Balance sheet ratios 01.01.2009 - 31.12.2009
Equity ratio [%]: 59.71
Liquidity ratio: 8.94
Return on total capital [%]: 20.20
Equity ratio
The
equity ratio indicates the portion of the equity as compared
to
the total capital. The higher the equity ratio, the better the
economic stability (solvency) and thus the
financial autonomy of
a
company.
Liquidity ratio
The
liquidity ratio shows the proportion between adjusted
receivables and net liabilities. The higher
the ratio, the lower
the
company's financial dependancy from external creditors.
Return on total capital
The
return on total capital shows the efficiency and return on
the
total capital employed in the company. The higher the return
on
total capital, the more economically does the company work
with the invested capital.
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2012 - 31.12.2012
ASSETS EUR 6,023,544.10
Fixed assets
EUR 78,271.12
Tangible assets
EUR 8,495.12
Other tangible assets / fixtures and
fittings
EUR 8,495.12
Financial assets
EUR 69,776.00
Other / unspecified financial assets EUR 69,776.00
Current assets
EUR 5,921,499.11
Stocks
EUR 944,778.20
Accounts receivable
EUR 3,812,304.77
Other debtors and assets
EUR 3,812,304.77
Liquid means
EUR 1,164,416.14
Remaining other assets
EUR 23,773.87
Accruals (assets)
EUR 23,773.87
LIABILITIES EUR 6,023,544.10
Shareholders' equity
EUR 4,737,652.22
Capital
EUR 50,000.00
Subscribed capital (share capital)
EUR 50,000.00
Balance
sheet profit/loss (+/-) EUR 4,687,652.22
Balance sheet profit / loss
EUR 4,687,652.22
Provisions
EUR 323,000.00
Liabilities
EUR 962,891.88
thereof total due to shareholders
EUR 55,713.77
Other liabilities
EUR 962,891.88
Unspecified other liabilities
EUR 962,891.88
thereof liabilities from social
security
EUR 1,037.45
PROFIT AND LOSS ACCOUNT (cost-summary method)
according to Comm.
Code
(HGB)
Gross result (+/-)
EUR 2,972,035.21
Staff expenses
EUR 823,074.36
Wages and salaries
EUR 767,077.44
Social security contributions and
expenses for pension plans and
benefits
EUR 55,996.92
Total depreciation EUR 4,006.05
Depreciation on tangible / intangible
asssets (incl. start-up and exp. of
bus.
EUR 4,006.05
Other operating expenses
EUR 514,408.70
Operating result from continuing
operations
EUR 1,630,546.10
Interest result (+/-)
EUR 26.65
Interest and similar income
EUR 26.65
Financial result (+/-) EUR 26.65
Result from ordinary operations (+/-)
EUR 1,630,572.75
Income tax / refund of income tax (+/-)EUR -526,344.71
Other taxes / refund of taxes
EUR -386.31
Tax
(+/-) EUR -526,731.02
Annual surplus / annual deficit
EUR 1,103,841.73
Type
of balance
sheet: Company balance sheet
Financial year: 01.01.2011 - 31.12.2011
ASSETS EUR 5,280,289.19
Fixed assets
EUR 76,788.12
Tangible assets
EUR 7,012.12
Other / unspecified tangible assets
EUR 7,012.12
Financial assets
EUR 69,776.00
Other / unspecified financial assets EUR 69,776.00
Current assets
EUR 5,181,291.46
Stocks
EUR 524,656.31
Accounts receivable
EUR 3,846,777.62
Other debtors and assets
EUR 3,846,777.62
Liquid means
EUR 809,857.53
Remaining other assets
EUR 22,209.61
Accruals (assets)
EUR 22,209.61
LIABILITIES EUR 5,280,289.19
Shareholders' equity
EUR 3,883,810.49
Capital
EUR 50,000.00
Subscribed capital (share capital)
EUR 50,000.00
Balance sheet profit/loss (+/-)
EUR 3,833,810.49
Profit / loss brought forward
EUR 2,704,482.23
Annual surplus / annual deficit EUR
1,129,328.26
Provisions
EUR 462,995.51
Liabilities
EUR 933,483.19
Other liabilities
EUR 933,483.19
Unspecified other liabilities
EUR 933,483.19
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.25 |
|
|
1 |
Rs.96.01 |
|
Euro |
1 |
Rs.70.72 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.